2022-09-13-世界卫生组织-INN_Proposed_List_128_-COVID-_Addendum_3页_157kb

Proposed INNs for COVID-19 mRNA Vaccines

• Proposed International Nonproprietary Names:

  • Davesomeranum
  • Famtozinameranum

• Vaccines Targeted: mRNA vaccines encoding pre-fusion stabilized variants of the SARS-CoV-2 spike glycoprotein for Omicron BA.4 and BA.5 sublineages.

• Consultation Period: Public consultation is open for two weeks due to exceptional pandemic circumstances, instead of the usual four months.

• Comment Deadline: Objections or comments must be submitted by 29 September 2022.

• Publication Details: Based on WHO Drug Information Vol. 36, No. 3, 2022 (Addendum 1), published on 15 September 2022.

• Additional Information: Includes chemical names, formulas, and CAS numbers; reference available at WHO resources.